Clinical TrialID 7328

To Evaluate the Efficacy and Safety of Amorphous Calcium Carbonate in RA Patient With Osteopenia or Osteoporosis

NCT05443360

Rheumatoid Arthritis|Osteopenia or Osteoporosis

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7328
Evidence Id
7328
Core Evidence Id
7328
Source Clinical Trial Id
7319
Herb2 Clinical Trial Id
HBCT007319
Nct Id
NCT05443360
Title
To Evaluate the Efficacy and Safety of Amorphous Calcium Carbonate in RA Patient With Osteopenia or Osteoporosis
Status
Phase
Study Result
No
Study Condition
Rheumatoid Arthritis|Osteopenia or Osteoporosis
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Intervention
DIETARY_SUPPLEMENT: DENSITY™ (Amorphous calcium carbonate, ACC)|DIETARY_SUPPLEMENT: Crystalized calcium carbonate (CCC)
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Double
Intervention Purpose
Supportive_Care
Gender
All
Age
Adult, Older_Adult
Enrollment
180
Outcome Measure
Mean change from baseline in bone mineral density (BMD) measured by dual-energy x-ray absorptiometry (DXA) in lumbar spine and total hip at Month 13, The BMD and the corresponding change from baseline will be summarized with descriptive statistics and the 95% CI by study groups. The difference in mean change from baseline in BMD between study groups will be analyzed by two sample t test. Additionally, the intra-group difference will be analyzed by paired t test., 12 months
Sponsor Collaborator
China Medical University Hospital
Funded By
OTHER
Location
China Medical University Hospital, Taichung, 404327, Taiwan|Taipei Veterans General Hospital, Taipei, 112201, Taiwan
Other Id
CMUH111-REC2-014
Start Date
2022-04-14
Primary Completion Date
2024-01-31
Completion Date
2024-01-31
First Posted
2022-07-05
Results First Posted
Last Update Posted
2022-07-05
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05443360
Title Cn
Title En
To Evaluate the Efficacy and Safety of Amorphous Calcium Carbonate in RA Patient With Osteopenia or Osteoporosis
Bilingual Status
semi_complete